NCT01734928 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 281
- group Id
- BG001
- value
- 278
- group Id
- BG002
- value
- 559
- units
- Participants
- groups
- description
- POM (Pomalidomide) * 4 mg/day on Days 1 to 14 of each 21-day treatment cycle BTZ (Bortezomib) * For Cycles 1 - 8: 1.3 mg/m2/dose on Days 1, 4, 8, and 11 of a 21-day cycle * For Cycles 9 onwards: 1.3 mg/m2/dose on Days 1 and 8 of a 21-day cycle DEX (Dexamethasone) * For Cycles 1 to 8, 20 mg/day (≤ 75 years old) or 10 mg/day (\> 75 years old) on Days 1, 2, 4, 5, 8, 9, 11 and 12 of a 21-day cycle. * For Cycles 9 and onward, 20 mg/day (≤ 75 years old) or 10 mg/day (\> 75 years old) on Days 1, 2, 8, and 9 of a 21-day cycle.
- id
- BG000
- title
- Treatment 1: POM+BTZ+LD-DEX
- description
- BTZ ((Bortezomib) * For Cycles 1 - 8: 1.3 mg/m2/dose on Days 1, 4, 8, and 11 of a 21-day cycle * For Cycles 9 onwards: 1.3 mg/m2/dose on Days 1 and 8 of a 21-day cycle DEX (Dexamethasone) * For Cycles 1 to 8, 20 mg/day (≤ 75 years old) or 10 mg/day (\> 75 years old) on Days 1, 2, 4, 5, 8, 9, 11 and 12 of a 21-day cycle. * For Cycles 9 and onward, 20 mg/day (≤ 75 years old) or 10 mg/day (\> 75 years old) on Days 1, 2, 8, and 9 of a 21-day cycle.
- id
- BG001
- title
- Treatment 2: BTZ+LD-DEX
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.13
- value
- 65.9
- group Id
- BG001
- spread
- 10.16
- value
- 66.1
- group Id
- BG002
- spread
- 10.14
- value
- 66.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 126
- group Id
- BG001
- value
- 131
- group Id
- BG002
- value
- 257
- title
- Female
- measurements
- group Id
- BG000
- value
- 155
- group Id
- BG001
- value
- 147
- group Id
- BG002
- value
- 302
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 31
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 244
- group Id
- BG001
- value
- 241
- group Id
- BG002
- value
- 485
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 43
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 22
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 21
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 237
- group Id
- BG001
- value
- 234
- group Id
- BG002
- value
- 471
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 45
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 281
- group Id
- BG001
- value
- 278
- group Id
- BG002
- value
- 559
- units
- Participants
- groups
- description
- POM (Pomalidomide) * 4 mg/day on Days 1 to 14 of each 21-day treatment cycle BTZ (Bortezomib) * For Cycles 1 - 8: 1.3 mg/m2/dose on Days 1, 4, 8, and 11 of a 21-day cycle * For Cycles 9 onwards: 1.3 mg/m2/dose on Days 1 and 8 of a 21-day cycle DEX (Dexamethasone) * For Cycles 1 to 8, 20 mg/day (≤ 75 years old) or 10 mg/day (\> 75 years old) on Days 1, 2, 4, 5, 8, 9, 11 and 12 of a 21-day cycle. * For Cycles 9 and onward, 20 mg/day (≤ 75 years old) or 10 mg/day (\> 75 years old) on Days 1, 2, 8, and 9 of a 21-day cycle.
- id
- BG000
- title
- Treatment 1: POM+BTZ+LD-DEX
- description
- BTZ ((Bortezomib) * For Cycles 1 - 8: 1.3 mg/m2/dose on Days 1, 4, 8, and 11 of a 21-day cycle * For Cycles 9 onwards: 1.3 mg/m2/dose on Days 1 and 8 of a 21-day cycle DEX (Dexamethasone) * For Cycles 1 to 8, 20 mg/day (≤ 75 years old) or 10 mg/day (\> 75 years old) on Days 1, 2, 4, 5, 8, 9, 11 and 12 of a 21-day cycle. * For Cycles 9 and onward, 20 mg/day (≤ 75 years old) or 10 mg/day (\> 75 years old) on Days 1, 2, 8, and 9 of a 21-day cycle.
- id
- BG001
- title
- Treatment 2: BTZ+LD-DEX
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.13
- value
- 65.9
- group Id
- BG001
- spread
- 10.16
- value
- 66.1
- group Id
- BG002
- spread
- 10.14
- value
- 66.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 126
- group Id
- BG001
- value
- 131
- group Id
- BG002
- value
- 257
- title
- Female
- measurements
- group Id
- BG000
- value
- 155
- group Id
- BG001
- value
- 147
- group Id
- BG002
- value
- 302
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 31
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 244
- group Id
- BG001
- value
- 241
- group Id
- BG002
- value
- 485
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 43
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 22
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 21
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 237
- group Id
- BG001
- value
- 234
- group Id
- BG002
- value
- 471
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 45
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle